Novartis Hepatitis C patent upheld by Delhi High Court

19-04-2022

Muireann Bolger

Novartis Hepatitis C patent upheld by Delhi High Court

II.studio / Shutterstock.com

In a victory for Novartis, the Delhi High Court in India has issued a permanent injunction against two India-based companies which had allegedly sought to make a generic version of the Hepatitis C treatment, Revolade (eltrombopag).


Novartis, Hepatitis C, patent, Metrochem, Medipol, Revolade, Promacta

LSIPR